Pricing Log in Create free account
Friday 6 November 2026 Export RPRX’s income statement to Excel — free account

Royalty Pharma PLC

RPRX Healthcare Biotechnology

Royalty Pharma PLC’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 5.06% from fiscal 2024.

Revenue
+13.3%
EPS
−51.5%
Free cash flow
+364.6%
Total debt
−4.00%

Quarter to September 2026, against a year earlier

67.22 0.35 −0.52%
Market cap
$39.0B
P/E
44.8×
Fwd P/E
27.3×
Dividend yield
1.37%
F-score
5/9
Altman Z
1.61
Beneish M
−2.83
Dividend safety
41/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Royalty Pharma PLC (RPRX) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Royalty Pharma PLC (RPRX) trades at a P/B ratio of 3.1×. Over the past ten years it has ranged from 0.0× (June 2020) to 3.1× (November 2026) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.7× 54.64%
FY2024 1.1× (11.90%)
FY2023 1.3× (30.74%)
FY2022 1.8× 12.32%
FY2021 1.6× (15.06%)
FY2020 1.9× —
FY2019 0.0× —
FY2018 0.0× —

Quarterly newest first

Period P/B ratio Change
Sep 2026 2.7× 4.21%
Jun 2026 2.6× 20.94%
Mar 2026 2.1× 23.35%
Dec 2025 1.7× 7.94%
25 more quarters

Against its own ten years

Low 0.0× High 3.1×
Ten-year median 1.6×
Current reading's percentile 100

P/B ratio against peers

Company P/B ratio
BNTX BioNTech SE Sponsored ADR compare 1.1×
RPRX Royalty Pharma PLC 3.1×
INCY Incyte Corporation compare 4.3×
ROIV Roivant Sciences Ltd. compare 5.4×
GMAB Genmab A/S Sponsored ADR compare 5.5×
ARGX argenex SE compare 6.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 7.5×
RVMD Revolution Medicines, Inc. compare 16.1×
INSM Insmed, Inc. compare 32.6×
Biotechnology industry median 2.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on RPRX